Category Archives: Health

Eric Lefkofsky’s Architype for Data Driven Healthcare

Many hear the name Eric Lefkofsky and think entrepreneurial kingpin. By co-founding companies like Groupon, Echo Global Logistics, and Uptake Technologies, he created a foundation of success in the world of tech startup companies. Now worth $1.7 billion according to Forbes, it may seem like he’s exited the world of company building and entered a life led by less involved endeavors.

Eric Lefkofsky statement would have been true, but then his wife Liz was diagnosed with breast cancer. A tumultuous time under the best of circumstances, Eric and Liz were baffled by the lack of comprehensive data to help develop treatments plans best suited for individual patients. Soon after Liz’s diagnosis, Lefkofsky took his degree from the University of Michigan and doctoral degree from the University of Michigan Law School and started one last company, Tempus.

Tempus still holds true to the nature of many of Lefkofsky’s other companies in that it is a data driven tech company. However, it isn’t geared towards local commerce or marketing. The goal of Tempus is to create a wheelhouse of data from doctors from some of the nation’s leading medical institutions. The startup established connections with the Mayo Clinic, the University of Chicago, Northwestern University, and the University of Michigan. Oncologists at these facilities send their patients to Tempus where they are then sequenced in Tempus’ lab. This data is stored and then each patient is paired up with cancer clinical information that matched their molecular profile. This comprehensive data is then sent back to the attending oncologist so that they can utilize whatever methods are most ideal for any individual nuances of that patient’s pathology to learn more: https://www.insidephilanthropy.com/guide-to-individual-donors/eric-lefkofsky.html click here.

This chain of events may seem like Tempus is a medical company, however, at the end of the day, it is still a tech company. It is merely driven by medical data in order to create a hub for cancer treatment methods and access. The impact for a company like Tempus will take years to see fully fulfilled. However, when those results reveal themselves, the impact will likely be life saving for millions.

Medical Publishing with Oncotarget

Oncotarget is a medical journal, which is peer-reviewed on a weekly basis, covering research papers on all dimensions of oncology. The medical journal was instituted in 2010, and Impact Journals did the publishing. The journal has two chief editors, Mikhail Blagosklonny and Andrei v. Gudkov from the Roswell Park Cancer Institute.

Mikhail Blagosklonny is an Associate Editor of Therapy and Cancer Biology, a member of Cell Death and Differentiation, Editorial Board and an Editor In Chief of Oncotarget, Ageing of Cells and Cell Cycle Journals. He is a professor of Oncology at the esteemed Roswell Park Cancer Center in Buffalo, New York. Roswell Park is one the institutions that offer comprehensive cancer treatment.

Visit ResearchGate to keep up to date with Mikhail’s latest work.

Oncotarget is a multidisciplinary journal featuring free access. The Journal posts the peer-reviewed papers every week. Additionally, each issue of the journal may be printed on special demand. The mission of the Oncotarget is to make scientific research results and papers rapidly and widely available. This is with the aim of maximizing the impact of research, as well as allowing discoveries to be shared instantly. By eliminating the border between the specialties, Oncotarget strived to link up the different fields in the biomedical sciences.

Under the leadership tenure of elite scientists, Oncotarget assists researcher add to the progress and growth of science. The journal’s primary goal is for people to live healthy, free from any diseases. Currently, Oncotarget offers free alt-metric reports for articles to provide real-time tracking of medical articles in both traditional and digital media platforms on Facebook. Furthermore, to the benefit of researchers and other scientists, Oncotarget is soon launching sections, in addition to oncology. Such additional categories include cardiology, endocrinology, immunology, pharmacology, MoI Biology and neuropathology cell among others.

The editors at Oncotarget are tasked with the responsibility of evaluating manuscripts on merit, quality of data, scientific novelty, and presentation regardless of the author’s citizenship, race, religious affiliations, and sexual orientation. The decision to publish a medical article is not founded on political policies and other agencies, rather the journal itself. The chief editors have the authority over all the editorial content of the journal even during the time of publishing.

The editorial staff is required not to disclose any information regarding the manuscripts to anyone other than the authors, reviewers, members of the editorial board and potential reviewers. Editors are additionally not allowed to utilize an unpublished material for other purposes but are required to keep the information confidential. The editorial team assesses the manuscripts without significant conflicts of interests stemming from collaborative, competitive, as well as other connections with the respective authors.

View Mikhail’s profile on Loop.

The Story of the Trio that founded Sweetgreen

When college students graduate, most of them have a mentality that they will land a job in a big company. This is not always the case. As witnessed in the recent past, many graduates are increasingly finding themselves stranded after completing their education. With many qualified candidates having to compete for the few jobs that the economies have to offer, many graduates are stranded unable to secure their dream jobs.

 

Many graduates end up working in fields and geographical areas they never thought or visualized themselves in. They are forced by situations to either accept to fill the available job positions or start private ventures.

 

When three Washington students, Jonathan Neman, Nicolas Jammet, and Nathaniel Ru, graduated from college, they decided to seek the help of friends and families in starting a venture named Sweetgreen.

 

In an interview, they said that they somehow felt that their fate would lead them to run their own business since neither of them had much interest in employment. The desire to build and run their own business and the need to provide better food choices to their society led to the birth of Sweetgreen.

 

 Jonathan Neman, Nicolas Jammet, and Nathaniel Ru had no idea that a few years down the line they would have a brand that is nationally recognized and adored by many. The trio credits their success to hard work and dedication to their goals.

 

Most of their investors were brought aboard by the spirit of the trio to succeed. The investors put their money in the startup because its founders’ business plan was precise and clear. The investors also acknowledged the commitment of the trio toward implementing the plan to the letter.

 

Sweetgreen was first established in Washington DC where the founders opened their iconic pioneer restaurant in 2007. Since then, they have expanded to other American cities and as at January 2016, they have over 30 retail locations.

 

Sweetgreen operates as a casual restaurant where people can walk in and order simple, healthy meals. The restaurant also offers seasonal meals themed from select regional cuisines. Their food products are grown organically.

 

Nathaniel Ru serves alongside his co-founders as the company’s CEO. He has served in this capacity for over nine years. He is fluent in both Spanish and English, which gives him an edge when negotiating international deals.